#aml search results

Superannuation and pension funds face growing ML, TF and PF expectations across the member lifecycle. hubs.la/Q046jrZC0 #AML #CTF #FinancialCrime #RegTech #Compliance

Report from Global Banking & Finance Review New report warns Austria is falling short in the global anti-money laundering fight. Strengthen compliance, invest in modern AML tech, and enhance cross-border oversight to curb illicit flows. #AML #KYC #MoneyL… globalbankingandfinance.com/austria-fallin…

FinCEN Proposes Reforms to AML/CFT Program Requirements natlawreview.com/article/fincen… #AML #finCEN #finance @GT_Law

Does #ChemoBrain stop when treatment does? Research from @AACR Annual Meeting found survivors of childhood #AML are at an increased risk of developing chemotherapy-related cognitive impairment (CRCI). bit.ly/3P0JthT #PedOnc #HemOnc #Leukemia

Attention CFC Candidates: Mastering the "Red Flags" isn’t just about passing, it’s about professional intuition. Know your indicators inside out. احفظ مؤشرات الاشتباه بدقة، فهي مفتاح نجاحك في الالتزام. Study smarter here: exams.academy #AML #CFC #Compliance #CME

Lo #AML♥️ 🥹🤩

Have you had your Anti Money Laundering policies and procedures reviewed recently? #AML #Fraud #CardPayments #UKBusiness #Money ift.tt/JYhK2RW

Teens, on May 5th, come play Switch Games and have pizza at the library! You can play ours or bring your own. Reasonable accommodations for individuals with disabilities can be made upon request by emailing [email protected]. #AML #ActonMA #LibraryEvents

FinCEN just dropped a record $80M AML fine on Canaccord Genuity. Their broker-dealer AML team: 4 people. 100+ daily alerts. 160 SARs never filed. When your compliance program can't actually run at your business's scale, this is where it ends. #AML #compliance #FinCEN

El mayor mito de la IA en finanzas: que reemplaza al humano. La realidad: lo potencia. Menos falsos positivos, detección en tiempo real y mejor respuesta al fraude 👇 soysentinel.com/ia-prevencion-… #AML #InteligenciaArtificial

New publication 📝Results from a retrospective cohort study, published in @Haematologica, show HMA + Ven yields comparable post-allo‑HSCT OS vs IC in older patients with adverse-risk AML (34.4 vs 28.3 months; p = 0.636). Learn more: bit.ly/4w0mtA7 #AML #leusm

Штрафы за AML в крипте взлетели до $900 млн за полгода 2025! KuCoin после бана в Австрии набирает экс-регуляторов FMA в AML-команду. Регуляторы давят - биржи становятся как банки. Кто выживет? #AML #CryptoReg #MiCA

KuCoin EU hires a new AML chief and deputies in Vienna weeks after Austria’s regulator banned the MiCA‑licensed exchange from taking on new business over compliance gaps. dlvr.it/TSHRFr #KuCoin #AML #MiCA #CryptoRegulation #Austria

No response from @rollbit Rollbit still holding my funds after altering my withdrawal and accusing me of AML violations they created. Also accused of multiple accounts with no evidence provided. Unauthorized changes made in my profile identified #Crypto #Bitcoin #AML

#FinCEN’s delay of the Investment Adviser #AML Rule may be temporary, but the impact on banks is immediate. As #compliance burdens shift, stronger due diligence and monitoring are critical. @GrantThorntonUS shares where leaders should focus now: bit.ly/4tBgBMd

How do you tell the difference between genuine access and an active threat when the IP is no longer enough? Discover Traffic Origin: hubs.ly/Q04dSh0j0 #ciso #soc #aml #kye #dprk

#AML -50% since September Today's rebound already losing steam Short sellers likely to persist

MLRO checklist 👇 • SAR logs • Training records • Risk updates Monthly reviews = stronger compliance. 👉 Stay ahead with CPD-certified AML training. 🌐 abmdigitaltraining.com/courses/ 📧 [email protected] #AML #Compliance #MLRO #SAR #CPD

🚨 10 arrests in Zurich expose the Black Axe playbook — romance scams → mule networks → crypto off-ramps. For AML & fraud teams, this is a diagnostic, not a headline. Funnel patterns. Stablecoin off-ramps. KYC-refresh blind spots. 📖 linkedin.com/pulse/black-ax… #AML #FinCrime

⚡️ @kucoincom expands #AML and compliance structure under #MiCAR with senior appointments, including a new AML Officer and deputy roles to strengthen governance, risk controls, and regulatory compliance in Europe. mpost.io/kucoin-eu-expa…

Outpatient low-dose VenAza combined with itraconazole reduced early mortality and hospitalizations while maintaining treatment efficacy. Read in Blood Global Hematology: ow.ly/uORw50YzhVq #AML

AML PDXs capture patients’ AML diversity, facilitate druggable targets identification and unlock new therapeutic frontiers in pAML. Read in Blood Advances: ow.ly/yPJ850YO1h8 #AML

Outcomes of NPM1-mutated AML in Brazil are influenced by limited access to novel therapies and low transplantation rates. Read in Blood Global Hematology: ow.ly/K3MY50YsyfQ #AML #Brazil

New publication 📝Results from a retrospective cohort study, published in @Haematologica, show HMA + Ven yields comparable post-allo‑HSCT OS vs IC in older patients with adverse-risk AML (34.4 vs 28.3 months; p = 0.636). Learn more: bit.ly/4w0mtA7 #AML #leusm

New publication 📝 An Italian modified Delphi consensus, published in Cancers, recommends an FLT3 inhibitor + intensive chemotherapy for fit patients with FLT3-mutated AML and repeat FLT3 testing for R/R AML. Learn more about AML: bit.ly/4b4vpuG #AML #AMLsm #MedNews

"Diagnosis and management of AML in pediatric patients: consensus recommendations from an international expert panel." Read the special report in Blood: ow.ly/y9uP50YCt3X #AML #BloodJournal #SpecialReport

GBBC member @sumsub partners with #ComplyAdvantage for strategic partnership to enhance #AML screening for compliance teams 🤝 Discover more ⤵️ sumsub.com/newsroom/sumsu…

Older patients with AML treated with intensive chemotherapy in Brazil experience a high early death rate and low overall survival. Read in Blood Global Hematology: ow.ly/t5lY50Yzhm8 #AML #Brazil

New publication 📝 Phase II RELAZA2 final long-term results, published in @BloodPortfolio, show 63% of patients with MRD‑positive MDS/AML in CR/CRi were relapse-free 6 months after azacitidine initiation (p < 0.0001). Learn more: bit.ly/4rDjgn4 #AML #AMLsm #MedNews

#AML londonstockexchange.com/news-article/A… Debt continues to rack up as per & it now looks like there’ll be race every quarter between JLR & Aston Martin to see who can get there cars over to US fastest at the start of every quarter Ludicrous position to be in

⚠️ In crypto #AML vendor selection, the same address often gets wildly different risk scores — not a bug, but a result of data sources, labeling, models & fund flow analysis. 🔹 To address this problem, We launches the Crypto AML Vendor Evaluation Checklist & Implementation

During the 67th annual meeting of the American Society of Hematology, researchers suggested results from a multicenter phase II study support switching frontline care for #AML patients. ow.ly/7mi450Yz9LM #CancerResearch

Caris Life Sciences Launches ChromoSeq Test to Streamline Genomic Analysis of Myeloid Malignancies - For More Information Visit shorturl.at/WWDpR @carisls #Myeloid_Cancers #Acute_myeloid_Leukemia #AML

Oryzon Secures Key U.S. Patent Covering Iadademstat Combination Therapies for Acute Myeloid Leukemia Treatment Through 2039 - For More Information Visit shorturl.at/f0GWF #OryzonGenomics #Rare_Diseases #AML #Acute_Myeloid_Leukemia #Leukemia #Orphan_Drugs

Evaluating the Impact of Fewer Frontline Intensive Chemotherapy Plus Venetoclax Consolidation Cycles on Outcomes in #AML |American Journal of Hematology | Blood Research Journal | Wiley Online Library onlinelibrary.wiley.com/doi/10.1002/aj… #leusm

New publication 📝 Results from an exploratory analysis of the phase III QuANTUM-First trial, published in @BloodPortfolio, show quizartinib maintenance was associated with prolonged OS and RFS vs placebo in ND FLT3-ITD #AML, with a pronounced benefit in non-transplanted and

Do's for #CompanySecretaries in Practice under #AML/#CFT Guidelines @MCA21India

PureTech Health Reports Promising Phase 1b Results for LYT-200 in R/R High-Risk Myelodysplastic Syndromes and R/R Acute Myeloid Leukemia - For More Information Visit shorturl.at/GaHs3 @PureTechH #Blood_Cancer #AML #MDS #Leukemia #Myelodysplastic_Syndromes #FDA

New review led by Reed Friend MD of @AtriumHealthWFB & P. Connor Johnson MD of @MassGenBrigham provides an overview of frailty-guided care in #MultipleMyeloma, #AML, and aggressive lymphomas. acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… @OncoAlert @AjayNookaMD #Lymphoma #HemOnc #LeuSM #GeriOnc

New publication 📝 A matching-adjusted indirect comparison, published in @AdvancesTherapy, shows comparable OS and rates of CR and CR+CRh between olutasidenib and ivosidenib in R/R IDH1m #AML, while olutasidenib extended median duration of CR+CRh. Learn more: